Recurrent Gastroesophageal Junction Adenocarcinoma

specific

The reemergence of gastroesophageal junction adenocarcinoma after a period of remission.

20

Centers

15

Active Trials

Cancer Funding

Top Centers for Recurrent Gastroesophageal Junction Adenocarcinoma(20)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
58.1
2
NCI Comprehensive
Active Research Program
58.1
3
NCI Comprehensive
Active Research Program
58.1
4
NCI Comprehensive
Active Research Program
58.1
5
NCI Comprehensive
Active Research Program
58.1
6
NCI Comprehensive
Active Research Program
58.1
7
Active Research Program
58.1
8
NCI Clinical
Active Research Program
58.1
9
NCI Comprehensive
Active Research Program
58.1
10
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
58.1
11
Active Research Program
58.1
12
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
58.1
13
Active Research Program
58.1
14
Active Research Program
58.1
15
Active Research Program
58.1
16
NCI Comprehensive
35.6
17
NCI Comprehensive
35.6
18
NCI Comprehensive
35.6
1935.6
20
NCI Comprehensive
35.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →